Risk-reducing Surgery in Women at Risk for Familial Breast or Ovarian Cancer

Area of Science:

• Oncology
• Genetics
• Preventive Medicine

Background:

• Inherited BRCA1 and BRCA2 mutations account for a significant proportion of breast (5%) and ovarian (10%) cancers.
• Approximately 1-2 in 1000 women carry these high-risk alleles, facing cumulative cancer risks of 60-85% for breast and 20-60% for ovarian cancer.
• Increased risk for contralateral breast cancer is noted in women with a history of unilateral breast cancer.

Purpose of the Study:

• To evaluate the effectiveness of an interdisciplinary approach for high-risk women with BRCA mutations.
• To assess the impact of genetic testing, counseling, and preventive strategies on cancer outcomes and mortality.

Main Methods:

• An interdisciplinary program initiated in 1997, expanded to 15 university hospital centers.
• Involves genetic testing, non-directive counseling, and structured screening for early breast cancer diagnosis.
• Offers risk-reducing surgical options: prophylactic bilateral salpingo-oophorectomy, prophylactic bilateral mastectomy, and contralateral prophylactic mastectomy.

Main Results:

• The program, supported by German Cancer Aid and health insurance companies since 2005, focuses on outcomes like reduced mortality.
• Structured screening and risk-reducing surgeries significantly decrease disease risk and mortality.
• Prophylactic bilateral salpingo-oophorectomy particularly reduces total mortality in BRCA mutation carriers.

Conclusions:

• Interdisciplinary centers provide comprehensive care for women with BRCA mutations.
• Early diagnosis and risk-reducing surgeries are crucial for managing hereditary breast and ovarian cancer risks.
• This approach demonstrably lowers disease-specific and overall mortality in high-risk individuals.